Literature DB >> 51189

Decreased premature ventricular contractions through use of the relaxation response in patients with stable ischaemic heart-disease.

H Benson, S Alexander, C L Feldman.   

Abstract

To determine whether decreased sympathetic-nervous-system activity achieved by the relaxation response could decrease premature ventricular contractions (P.V.C.s), eleven ambulatory patients with proven, stable ischaemic heart-disease and P.V.C.s were investigated. The patients, who were taking no medication for the P.V.C.s, were trained to elicit regularly the relaxation response through a non-cultic psychological technique. The frequency of the P.V.C.s was measured by computer analysis of Holter monitor tapes for 2 complete days before learning the technique, which was learned in approximately 5 minutes after the second day. Patients were instructed to evoke the response for 20 minutes twice daily thereafter. After 4 weeks, a reduced frequency of P.V.C.s was documented in eight of the eleven patients. This effect was especially striking during the sleeping hours and less so during the entire monitoring session. The relaxation response is a simple, no cost, non-pharmacological mechanism without side-effects which seemed to decrease the frequency of P.C.V.s in most patients with ischaemic heart-disease.

Entities:  

Mesh:

Year:  1975        PMID: 51189     DOI: 10.1016/s0140-6736(75)92895-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Psychopharmacological management of post-myocardial depression and anxiety.

Authors:  R C Monks
Journal:  Can Fam Physician       Date:  1981-07       Impact factor: 3.275

2.  Autonomic involvement in idiopathic premature ventricular contractions.

Authors:  Wenbo He; Zhibing Lu; Mingwei Bao; Lilei Yu; Bo He; Yijie Zhang; Xiaorong Hu; Bo Cui; Bing Huang; Hong Jiang
Journal:  Clin Res Cardiol       Date:  2013-02-06       Impact factor: 5.460

3.  Biofeedback and relaxation training in the treatment of psychophysiological disorders: or are the machines really necessary?

Authors:  B V Silver; E B Blanchard
Journal:  J Behav Med       Date:  1978-06

4.  Daily relaxation response breaks in a working population: I. Effects on self-reported measures of health, performance, and well-being.

Authors:  R K Peters; H Benson; D Porter
Journal:  Am J Public Health       Date:  1977-10       Impact factor: 9.308

5.  Tailoring Cognitive-Behavioral Therapy to Treat Anxiety Comorbid with Advanced Cancer.

Authors:  Joseph A Greer; Elyse R Park; Holly G Prigerson; Steven A Safren
Journal:  J Cogn Psychother       Date:  2010-01-01

6.  Frequency of private spiritual activity and cardiovascular risk in postmenopausal women: the Women's Health Initiative.

Authors:  Elena Salmoirago-Blotcher; George Fitchett; Kathleen M Hovey; Eliezer Schnall; Cynthia Thomson; Christopher A Andrews; Sybil Crawford; Mary Jo O'Sullivan; Stephen Post; Rowan T Chlebowski; Judith Ockene
Journal:  Ann Epidemiol       Date:  2013-05       Impact factor: 3.797

Review 7.  Sitting-meditation interventions among youth: a review of treatment efficacy.

Authors:  David S Black; Joel Milam; Steve Sussman
Journal:  Pediatrics       Date:  2009-08-24       Impact factor: 7.124

8.  Phone-delivered mindfulness training for patients with implantable cardioverter defibrillators: results of a pilot randomized controlled trial.

Authors:  Elena Salmoirago-Blotcher; Sybil L Crawford; James Carmody; Lawrence Rosenthal; Gloria Yeh; Mary Stanley; Karen Rose; Clifford Browning; Ira S Ockene
Journal:  Ann Behav Med       Date:  2013-10

9.  An update on mindfulness meditation as a self-help treatment for anxiety and depression.

Authors:  Teresa M Edenfield; Sy Atezaz Saeed
Journal:  Psychol Res Behav Manag       Date:  2012-11-23

10.  Dynamic correlations between heart and brain rhythm during Autogenic meditation.

Authors:  Dae-Keun Kim; Kyung-Mi Lee; Jongwha Kim; Min-Cheol Whang; Seung Wan Kang
Journal:  Front Hum Neurosci       Date:  2013-07-31       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.